Fexaramine,cas:574013-66-4
3-[3-[(cyclohexylcarbonyl)[[4-(dimethylamino)[1,1-biphenyl]-4-yl]methyl]amino]phenyl]-2-propenoic acid, methyl ester
Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
---|---|---|---|---|
R-XASYS-00508 | 10mg | 405.00 | + Add to cart |
|
R-XASYS-00508 | 25mg | 778.00 | + Add to cart |
|
|
Product description
Fexaramine(C32H36N2O3,496.6) is a novel, synthetic, small-molecule agonist of the farnesoid X receptor (FXR) that was first identified in 2011. It was initially developed as a potential therapeutic agent for metabolic diseases such as type 2 diabetes and non-alcoholic fatty liver disease. FXR is a nuclear hormone receptor that is found in the liver, intestine, and other tissues and is involved in the regulation of bile acid, glucose, and lipid metabolism.
Appearance | N/A |
---|---|
Molecular Weight | N/A |
Purity | >90% |
Solubility | N/A |
Storage | -20℃, protected from light and moisture |
Transportation | 4-25℃ temperature for up to 3 weeks |
Stability | 1 year |
Document
Related Product